Nanexa is granted patent in India
Nanexa AB (publ) today announced that the company has been granted a patent in India relating to its PharmaShell® technology. This patent covers the relevant manufacturing method, coated drug particles that result therefrom, and pharmaceutical composition containing those particles.
"I am pleased to note that we have now established strong global patent protection for PharmaShell. Today's announcement is an important milestone for which we have worked long and hard. India is both a large production country and a significant market for pharmaceuticals, and it is important that we obtained strong patent protection there as well”, said David Westberg, CEO of Nanexa.
The PharmaShell patent is already granted in the US, Japan, Korea, China, Canada and in European countries. With the approval in India, Nanexa now has patents in all countries where it applied for patent protection.